CIBC World Market’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,325
Closed -$220K 1358
2024
Q4
$220K Sell
9,325
-2,007
-18% -$49.4K ﹤0.01% 1273
2024
Q3
$290K Buy
+11,332
New +$289K ﹤0.01% 1140
2022
Q3
Sell
-9,285
Closed -$292K 1228
2022
Q2
$292K Sell
9,285
-35,439
-79% -$1.24M ﹤0.01% 1028
2022
Q1
$2.05M Buy
44,724
+21,714
+94% +$1.04M 0.01% 579
2021
Q4
$1.41M Buy
23,010
+2,868
+14% +$198K ﹤0.01% 696
2021
Q3
$1.5M Buy
20,142
+242
+1% +$20.3K ﹤0.01% 679
2021
Q2
$1.84M Sell
19,900
-26,069
-57% -$2.22M 0.01% 616
2021
Q1
$4.08M Buy
45,969
+39,377
+597% +$3.91M 0.01% 403
2020
Q4
$615K Buy
+6,592
New +$525K ﹤0.01% 893

Other funds holding ARKG

CIBC World Market's ARKG Position: Q1 2025 in Review

CIBC World Market sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 9,325 shares — an estimated $220K sold.

CIBC World Market first reported a position in ARKG in Q4 2020 and held it in 9 quarters. The position peaked at $4.08M in Q1 2021. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • CIBC World Market reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • CIBC World Market sold 9,325 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $220K.
  • CIBC World Market first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 9 quarters.
  • CIBC World Market's ARK Genomic Revolution ETF position peaked at $4.08M in Q1 2021.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on CIBC World Market's 13F filing for Q1 2025, filed 14 May 2025.